Moreover, we observed that the CN gain of PDGFRA pathway was associated with a higher proportion of LOH alterations and higher CNV burden in most cancers such as KIRC, LUAD, SKCM, and UCEC, while the association was in the opposite direction in ACC (Fig. 3A, B). The gene discussed is PDGFRA; the disease is adrenal cortex carcinoma.